×
Choose Speciality

EXPLORE!

LOGIN

Lenalidomide may be an alternative treatment of recurrent erythema multiforme

  1334 Views

eMediNexus    11 March 2018

Lenalidomide may be an alternative (off-label) to thalidomide for the treatment of recurrent erythema multiforme as reported in a series of three cases published online February 14, 2018 in JAMA Dermatology. Adverse events may limit the use of thalidomide as long-term treatment.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.